Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.

Sheppard JP, Singh S, Fletcher K, McManus RJ, Mant J.

BMJ. 2012 Jul 12;345:e4535. doi: 10.1136/bmj.e4535.

2.

Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.

Mohammed MA, El Sayed C, Marshall T.

Med Decis Making. 2012 May-Jun;32(3):498-506. doi: 10.1177/0272989X12437246. Epub 2012 Feb 22.

PMID:
22357626
3.

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.

Fleetcroft R, Schofield P, Ashworth M.

BMC Health Serv Res. 2014 Sep 20;14:414. doi: 10.1186/1472-6963-14-414.

4.

Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.

Sheppard JP, Fletcher K, McManus RJ, Mant J.

Br J Gen Pract. 2014 Jan;64(618):e38-46. doi: 10.3399/bjgp14X676447.

5.
6.

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.

7.

Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study.

Homer K, Boomla K, Hull S, Dostal I, Mathur R, Robson J.

Br J Gen Pract. 2015 Aug;65(637):e538-44. doi: 10.3399/bjgp15X686113.

8.

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.

Vinogradova Y, Coupland C, Brindle P, Hippisley-Cox J.

BMJ. 2016 Jun 28;353:i3305. doi: 10.1136/bmj.i3305.

9.

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

van Staa TP, Smeeth L, Ng ES, Goldacre B, Gulliford M.

Heart. 2013 Nov;99(21):1597-602. doi: 10.1136/heartjnl-2013-303698. Epub 2013 Jun 4.

10.

Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.

Hemming K, Ryan R, Gill P, Westerby P, Jolly K, Marshall T.

Br J Gen Pract. 2016 Oct;66(651):e758-67. doi: 10.3399/bjgp16X686629. Epub 2016 Aug 15.

PMID:
27528707
11.

Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.

Wu J, Zhu S, Yao GL, Mohammed MA, Marshall T.

PLoS One. 2013 Jul 26;8(7):e67611. doi: 10.1371/journal.pone.0067611. Print 2013.

12.

Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data.

Matthews A, Herrett E, Gasparrini A, Van Staa T, Goldacre B, Smeeth L, Bhaskaran K.

BMJ. 2016 Jun 28;353:i3283. doi: 10.1136/bmj.i3283.

13.

Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.

Chapman RH, Petrilla AA, Berman L, Benner JS, Tang SS.

Am J Cardiovasc Drugs. 2009;9(5):299-308. doi: 10.2165/11312110-000000000-00000.

PMID:
19791839
14.

Statins for secondary cardiovascular disease prevention for older primary care patients.

Niska R, Han B.

J Natl Med Assoc. 2009 Jul;101(7):705-10.

PMID:
19634592
15.

Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial.

Persell SD, Lloyd-Jones DM, Friesema EM, Cooper AJ, Baker DW.

J Gen Intern Med. 2013 Apr;28(4):554-60. doi: 10.1007/s11606-012-2268-1. Epub 2012 Nov 11.

16.

Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis.

Sheppard JP, Fletcher K, McManus RJ, Mant J.

Br J Gen Pract. 2014 Oct;64(627):e641-8. doi: 10.3399/bjgp14X681817.

17.
18.

Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.

Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G.

J Public Health (Oxf). 2007 Mar;29(1):40-7. Epub 2006 Oct 27.

PMID:
17071815
19.

Age, sex and practice variations in the use of statins in general practice in England and Wales.

Majeed A, Moser K, Maxwell R.

J Public Health Med. 2000 Sep;22(3):275-9.

PMID:
11077897
20.

Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough.

Dodhia H, Kun L, Logan Ellis H, Crompton J, Wierzbicki AS, Williams H, Hodgkinson A, Balazs J.

BMJ Open. 2015 Dec 9;5(12):e008678. doi: 10.1136/bmjopen-2015-008678.

Supplemental Content

Support Center